Kaynes Tech, Sun Pharma, and four additional mid-cap stocks HDFC Securities is optimistic; take heed of the aims

The brokerage’s stock list covers a variety of industries, from healthcare to real estate. Many investors are unsure on where to put their money after the benchmark Nifty50 and Sensex reached new all-time highs on Dalal Street.

1/7 HDFC Securities is optimistic on Sun Pharma, Kaynes Tech, and four other mid-cap equities.

For long-term investors, HDFC Securities, a domestic brokerage, offers a few stock recommendations. The brokerage’s stock list covers a variety of industries, from healthcare to real estate. The following are some buy suggestions for the investment made by HDFC Securities:

2/7 Sun Pharmaceutical Industries Limited,

With a target price of Rs 1,750, HDFC continues to maintain a buy call on shares of Sun Pharmaceutical Industries Ltd., a well-known pharmaceutical firm.

3/7 Star Cement Ltd.

Star Cement, Inc.
With a target price of Rs 250, the brokerage has kept its ‘buy’ rating on Star Cement shares.

4/7 Galaxy Surfactants Ltd.

Targeting a price of Rs 3,101, Galaxy Surfactants Ltd. is the subject of a ‘buy’ call from HDFC Securities.

5/7 India’s Kaynes Technologies, Ltd.

With a target price of Rs 3,250, HDFC Securities has maintained a “buy” call on the technology sector stock Kaynes Technology India Ltd.

6/7 Sansera Engineering Company, Inc.

Purchasing Sansera Engineering shares with a target price of Rs 1,190 has been advised by the brokerage.

7/7 Sobha Enterprises

The analysts at HDFC Securities advise purchasing Sobha Ltd. stock with a target price of Rs. 2,150.

Account opning link:

1. Groww Account- https://app.groww.in/v3cO/kyrp1zph
2. Kotak neo Account https://kotaksecurities.ref-r.com/c/i/32531/109103906